Growth factor delivery for bone tissue engineering

Journal of Drug Targeting

Volumn 9, Issue 6, 2001, Pages 407-429

  Gittens, Sébastien A ^a   Uludag, Hasan ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Bone healing; Bone tissue engineering; Drug targeting; Growth factors

Indexed keywords

ACIDIC FIBROBLAST GROWTH FACTOR; ACTIVIN; ALENDRONIC ACID; BASIC FIBROBLAST GROWTH FACTOR; BIOMATERIAL; BISPHOSPHONIC ACID DERIVATIVE; BONE MORPHOGENETIC PROTEIN; CLODRONIC ACID; DEXAMETHASONE; ETIDRONIC ACID; GROWTH DIFFERENTIATION FACTOR 5; GROWTH FACTOR; IBANDRONIC ACID; PAMIDRONIC ACID; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT BONE MORPHOGENETIC PROTEIN 4; RECOMBINANT CYTOKINE; RECOMBINANT OSTEOGENIC PROTEIN 1; RECOMBINANT SOMATOMEDIN C; RISEDRONIC ACID; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TECHNETIUM 99M; TILUDRONIC ACID; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DISEASE; BONE INJURY; BONE REGENERATION; BONE REMODELING; BONE TISSUE; BONE TURNOVER; CONTROLLED STUDY; DRUG ABSORPTION; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG POTENTIATION; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG TARGETING; FRACTURE HEALING; HUMAN; LIFESPAN; MOUSE; NONHUMAN; OSSIFICATION; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RAT; TISSUE ENGINEERING; TREATMENT OUTCOME;

EID: 0035693239     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10611860108998776     Document Type: Article

References (165)

1. "Implications of cellular and molecular biology advances in periodontal regeneration"
2. "BMP-2 for intramuscular bone induction: Effect in squirrel monkeys is dependent on implantation site"
3. "Bone morphogenetic protein induces bone in the squirrel monkey, but bone matrix does not"
4. "Benefit of systemically administered rhIGF-I and rhIGF/IGFBP-3 on cancellous bone in ovariectomized rats"
5. "Systemic administration of rhIGF-I or rhIGF-I/IGFBP-3 increases cortical bone and lean body mass in ovariectomized rats"
6. "Treatment of ovariectomized rats with the complex of rhIGF-I/IGFBP-3 increases cortical and cancellous bone mass and improves structure in the femoral neck"
7. "The effect of systemically administered rhIGF-I/IGFBP-3 complex on cortical bone strength and structure in ovariectomized rats"
8. "Receptor and heparin binding domains of basic fibroblast growth factor"
9. "Bone graft materials"
10. "Effect of 17β-estradiol-bisphosphonate conjugates, potential bone-seeking estrogen pro-drugs, on 17β-estradiol serum kinetics on bone mass in rats"
11. "Short-term local injections of transforming growth factor-beta 1 decrease ovariectomy-stimulated osteoclastic resorption in vivo in rats"
12. "Structural requirement for bisphosphonate action in vitro"
13. "Recombinant human bone morphogenetic protein-7 in maxillary sinus floor elevation surgery in 3 patients compared to autogenous bone grafts. A clinical pilot study"
14. "Design of biomimetic habitats for tissue engineering with P-15, a synthetic peptide analogue of collagen"
15. "Laparoscopic anterior spinal arthrodesis with rhBMP-2 in a titanium interbody threaded cage"
16. "Posterolateral lumbar intertransverse process spine arthrodesis with recombinant human bone morphogenetic protein 2/hydroxyapatite-tricalcium phosphate after laminectomy in the nonhuman primate"
17. "The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: A preliminary report"
18. "Regulation of fracture repair by growth factors"
19. "Animal studies of application of rhBMP-2 in maxillofacial reconstruction"
20. "Feasibility study evaluating rhBMP-2/absorbable collagen sponge for maxillary sinus floor augmentation"
21. "The influence of the method of preparation of bone-scanning agent 99mTc(Sn)EHDP on its tissue distribution in the rat"
22. "Principles of tissue engineering applied to programmable osteogenesis"
23. "Tissue engineering of bone: Cell based strategies"
24. "Bone biology. II: Formation, form, modeling, remodeling, and regulation of cell function"
25. "Stabilization of recombinant human basic fibroblast growth factor by chemical modifications of cysteine residues"
26. "Repair of segmental bone defects in the rat: An experimental model of human fracture healing"
27. "Protein delivery from biodegradable microspheres"
28. "Evaluation of recombinant human bone morphogenetic protein-2 in oral applications including the use of endosseous implants: 3-year results of a pilot study in humans"
29. "The therapeutic use of biophosphonates"
30. "Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates"
31. "Generalizations regarding the process and phenomenon of osseointegration. Part II. In vitro studies"
32. "Hypotensive activity of fibroblast growth factor"
33. "CNS distribution of fibroblast growth factor injected into the blood stream"
34. "Dual role for the latent transforming growth factor-beta binding protein in storage of latent TGF-beta in the extracellular matrix and as a structural matrix protein"
35. "Bone injury, regeneration, and repair"
36. "Bone-seeking radiopharmaceuticals"
37. "Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow"
38. "The osteoblast: A sophisticatred fibroblast under central surveillance"
39. "Transforming growth factor-beta 1: Induction of bone morphogenetic protein genes expression during endochondral bone formation in the baboon, and synergistic interaction with osteogenic protein-1 (BMP-7)"
40. "Systemic administration of acidic fibroblast growth factor (FGF-1) prevents bone loss and increases new bone formation in ovariectomized rats"
41. "Perivascular and intravenous administration of basic fibroblast growth factor: Vascular and solid organ deposition"
42. "The cell and molecular biology of fracture repair"
43. "Towards a molecular understanding of skeletal development"
44. "Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with amino-terminal sequence of bovine brain acidic FGF"
45. Chemical, biochemical and medicinal properties of the diphosphonates
46. "RGD-coated titanium implants stimulate increased bone formation in vivo"
47. "Inhibition of bone resorption by bisphosphonates: Interactions between bisphosphonates, osteoclasts and bone"
48. "Bisphosphonates-history and experimental basis"
49. "Infusion of platelet-derived growth factor or bFGF induces selective glomerular mesengial cell proliferation and matrix accumulation in rats"
50. "Skeletal uptake of diphosphonate: A review"
51. "Osteotropic drug delivery system based on bisphosphonate prodrug. IV Effects of osteogropic estradiol on bone mineral density and uterine weight in overiectomized rats"
52. "Effect of physiochemical properties of engineered thermoreversible polymers on retention of bone Morphogenetic Protein-2 in vivo"
53. Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women
54. "Comparison of canine and non-human primate animal models for periodontal regenerative therapy: Results following a single administration of PDGF/IGF-I"
55. "Comparative effects of platelet-derived growth factor-BB and insulin-like growth factor-I, individually and in combination, on periodontal regeneration in Macaca fascicularis"
56. "Labeling of basic fibroblast growth factor with digoxigenin: A non-radioactive probe for biochemical and cytological applications"
57. Effects of short-term recombinant human insulin-like growth factor I administration on bone turnover in osteopenic women with anorexia nervosa
58. "The importance of the hematoma for fracture healing in rats"
59. "Bone formation and reosseointegration in peri-implantitis defects following surgical implantation of rhBMP-2"
60. "Bone formation and osseointegration stimulated by rhBMP-2 following subantral augmentation procedures in nonhuman primates"
61. Pathophysiology of delayed healing
62. "Preparation of fluorescent basic fibroblast growth factor: Localization in living retinal microvascular endothelial cells"
63. "Designing biomaterials of direct biological responses"
64. "The use of recombinant human bone morphogenetic protein 2 (rhBMP-2) to promote spinal fusion in a nonhuman primate anterior interbody fusion model"
65. "Peptide growth factor interactions in embryonic and fetal growth"
66. "Bone remodelling"
67. "The pharmacokinetics and distribution of pamidronate for a range of doses in the mouse"
68. "Distribution of IV-administered acidic and basic FGF in the mouse"
69. "Targeted delivery of antineoplastic agent to bone: Biodistribution studies with technetium-99m-labeled gem-bisphosphonate conjugated of methotrexate"
70. "A phase I/II clinical trial to evaluate a combination or recombinant human platelet-derived growth factor BB and recombinant human insulin-like growth factor-I in patients with periodental disease"
71. "The formation of growth and skeletal tissues"
72. "Contrasting effects of parathyroid hormone and insulin-like growth factor I in an aged ovariectomized rat model of postmenopausal osteoporosis"
73. "The role of recombinant human bone morphogenetic protein-2 in PLGA capsules at an extraskeletal site of the rat"
74. Effects of growth hormone and insulin-like growth factor I in men with idiopathic osteoporosis
75. "Influence of pyrophosphate on the exchange of calcium and phosphate ions on hydroxyapatite"
76. "In vivo effects of transforming growth factor-beta 2 in ovariectomized rats"
77. "Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis"
78. "Alendronate in the treatment of Paget's disease of bone"
79. "Isolation of recombinant BMP receptor IA ectodomain and its 2:1 complex with BMP-2"
80. "Crystal structure of the BMP-2-BPIA ectodomain complex"
81. "Anti-cancer-linked phosphonates with antiosteolytic and antineoplastic properties: A promising perspective in the treatment of bone-related malignancies"
82. "Extracellular matrix cell adhesion peptides: Functional applications in orthopedic materials"
83. "Fate of biotinated basic fibroblast growth factor in the retina following intravitreal injection"
84. "Bone anabolic effects of basic fibroblast growth factor in ovariectomized rats"
85. "Physiological disposition of alendronate, a potent antiosteolytic bisphosphonate, in laboratory animals"
86. "Controlled release of transforming growth factor beta 1 from biodegradable polymer microparticles"
87. "Birth and death of bone cells: Basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis"
88. "Maxillary sinus augmentation in the non-human primate: A comparative radiographic and histologic study between recombinant human osteogenic protein-1 and natural bone mineral"
89. "The biology of fracture healing: Optimizing outcome"
90. "Posterolateral intertransverse process spinal arthrodesis with rhBMP-2 in a nonhuman primate: Important lessons learned regarding dose, carrier, and safety"
91. Recombinant human insulin-like growth factor I, recombinant human growth hormone and sex steroids: Effects on markers of bone turnover in humans
92. "The histopathology of kidney changes in rats and monkeys following intravenous administration of massive doses of FCE 26184, human basic fibroblast growth factor"
93. "Residual lateral wall defects following sinus grafting with recombinant human osteogenic protein-1 or Bio-Oss in the chimpanzee"
94. "Knee: Role and results of allografts"
95. "The biology of fracture healing in long bones"
96. "The effect of systemically administered PDGF-BB on the rodent skeleton"
97. "Osteonecrosis of the femoral head. Potential treatment with growth and differentiation factors"
98. "Growing new organs"
99. "Restoration of segmental bone defects in rabbit radius by biodegradable capsules containing recombinant human bone morphogenetic protein-2"
100. "Stimulation of trabecular bone formation by insulin-like growth factor I in adult ovariectomized rats"
101. "Regeneration of periodontal tissues by basic fibroblast growth factor"
102. "Effect of basic fibroblast growth factor (bFGF) on bone formation in growing rats"
103. "Stimulation of endosteal bone formation by systemic injections of recombinant basic fibroblast growth factor in rats"
104. "Stimulation of bone formation by intraosseous injection of basic fibroblast growth factor in ovariectomised rats"
105. "The effects of recombinant human insulin-like growth factor (rhIGF)-1 and rhIGF-1/IGF binding protein-3 administration on rat osteopenia induced by ovariectomy with concomitant bilateral sciatic neurectomy"
106. "Potential role of gene therapy in the enhancement of fracture healing"
107. "Osteoinductive applications of regional gene therapy"
108. "Stem cell technology and bioceramics: From cell to gene engineering"
109. "Theoretical and methodological approach"
110. "The use of bisphosphonates in the treatment of osteoporosis"
111. "The mechanism of coupling: A role for the vasculature"
112. "A new model for the regulation of bone resorption with particular reference to the effects of bisphosphonates"
113. Controlled release of platelet-derived growth factor from porous poly(L-lactide) membranes for guided tissue regeneration
114. "Mitogenic responsiveness of human bone cells in vitro to hormones and growth factors decreases with age"
115. "Biotinylated basic Fibroblast Growth Factor is biologically active"
116. "In vitro distributions of some component fractions of Tc(NaBH4)-HEDP mixtures separated by anion exchange high pressure liquid chromatography"
117. "Understanding and controlling the bone-implant interface"
118. "Anabolic effects of basic fibroblast growth factor in the tibial diaphysis of ovariectomized rats"
119. "Novel formulation of fibroblast growth factor-2 in a hyaluronan gel accelerates fracture healing in nonhuman primates"
120. "Osteogenic protein-1, a bone morphogenetic protein, induces angiogenesis in the chick chorioallantoic membrane and synergizes with basic fibroblast growth factor and transforming growth factor-beta 1"
121. "Symbiosis of biotechnology and biomaterials: Applications in tissue engineering of bone and cartilage"
122. "Role of morphogenetic proteins in skeletal tissue engineering and regeneration"
123. "Limited chondro-osteogenesis by recombinant human transforming growth factor-beta 1 in calvarial defects of adult baboons (Papio ursinus)"
124. "Induction of cementogenesis by recombinant human osteogenic protein-1 (hop-1/bmp-7) in the baboon (Papio ursinus)"
125. "Recombinant transforming growth factor-beta 1 induces endochondral bone in the baboon and synergizes with recombinant osteogenic protein-1 (bone morphogenetic protein-7) to initiate rapid bone formation"
126. "Induction of endochondral bone formation by recombinant human transforming growth factor-beta 2 in the baboon (Papio ursinus)"
127. "Long-term evaluation of bone formation by osteogenic protein 1 in the baboon and relative efficacy of bone-derived bone morphogenetic proteins delivered by irradiated xenogeneic collagenous matrices"
128. "Therapeutic approaches to bone diseases"
129. "Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity"
130. "Platelet-derived growth factor and dexamethasone combined with a collagen matrix induce regeneration of the periodontium in monkeys"
131. "Induction of reparative dentine formation in monkeys by recombinant human osteogenic protein-1"
132. "Activin increases bone mass and mechanical strength of lumbar vertebrae in aged ovariectomized rats"
133. "Incorporation of heparin-binding peptides into fibrin gels enhances neurite extension: An example of designer matrices in tissue engineering"
134. "Gene therapy for osteoinduction"
135. "Crystal structure of Human Bone Morphogenetic Protein-2 at 2.7 Å resolution"
136. "Tissue engineers build new bone"
137. "Complete degradation of type X collagen requires the combined action of interstitial collagenase and osteoclast-derived cathepsin-B"
138. "Cathepsin expression during skeletal development"
139. "Inductive activity of recombinant human growth and differentiation factor-5"
140. "Transforming growth factor-beta and p-21: Multiple molecular targets of decorin-mediated suppression of neoplastic growth"
141. "Hormone regulation of chondrocyte and endochondral bone formation"
142. "Transplantation of musculoskeletal tissues"
143. "Synthesis of gem-bisphosphonic methotrexate conjugates and their biological response towards Walker's osteosarcome"
144. "Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities"
145. "Skull bone regeneration in primates in response to basic fibroblast growth factors"
146. "Opposite effects of insulin-like growth factor-I on the formation of trabecular and cortical bone in adult female rats"
147. "Bone resorption by osteoclasts"
148. "Synthesis and characterization of thermoreversible, protein conjugating-polymers based on N-isopropylacrylamide"
149. "Biotinated Bone Morphogenetic Protein-2: In vitro and in vivo activity"
150. "rhBMP/collagen sponges as osteoinductive devices: Effects of sponge characteristics and protein pI on in vivo rhBMP pharmacokinetics"
151. "Bisphosphonate conjugation to proteins as a means to impart bone affinity"
152. "Bone affinity of a bisphosphonate-conjugated protein in vivo"
153. "Implantation of recombinant human bone morphogenetic proteins with biomaterials: Correlation between protein pharmacokinetics and osteoinduction in rat ectopic model"
154. "Engineering temperature-sensitive poly(N-isopropylacrylamide) polymers as carriers of therapeutic proteins"
155. "Effects of IGF-I, alone and in combination with 17 beta-oestradiol, on bone remodeling parameters in ovariectomised rats"
156. "Effects of recombinant human growth hormone and insulin-like growth factor-I, with or without 17 beta-estradiol, on bone and mineral homeostasis of aged ovariectomized rats"
157. "Localization of osteogenic protein-1 (bone morphogenetic protein-7) during human embryonic development: High affinity binding to basement membranes"
158. "Characterization, stability, and formulations of basic fibroblast growth factor"
159. "Extracellular matrix remodeling during morphogenesis"
160. "The fate of the intravenously administrated bFGF and the effect of heparin"
161. "Effect of new bisphosphonate acids on tumor-induced bone destruction in the rat"
162. "Carrier system for bone morphogenetic proteins"
163. "Growth factor release from gelatin hydrogel for tissue engineering"
164. "Bone regeneration by transforming growth factor beta 1 released from a biodegradable hydrogel"
165. "Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I"